WHO Releases Blueprint to Help Countries Respond to Antifungal Resistance

The document seeks to provide a framework to strengthen responses to fungal diseases as their prevalence grows.

Key Highlights

  • The WHO's blueprint targets four key areas: awareness, access to diagnostics and treatments, surveillance, and environmental factors.
  • Fungal infections impact over 300 million people annually, yet remain under-recognized and poorly managed globally.
  • The rise of resistant fungi like C. auris highlights the urgent need for coordinated international response efforts.
  • Climate change, global travel, and agricultural pesticide use are contributing to the expanding threat of fungal diseases.
  • Enhanced research, lab networks, and equitable access to antifungal medications are critical components of the WHO's strategy.

The WHO has released a blueprint to "help countries respond to the growing threat of fungal infections and antifungal resistance." CIDRAP has the news.

The document "provides a framework to strengthen national and regional responses to fungal diseases, which affect more than 300 million people each year yet remain widely under-recognized, underdiagnosed, and poorly managed." It represents the latest in an ongoing effort by the WHO to "address a threat that the international health organization believes is expanding because of climate change, increased global travel, and widespread use of antifungal pesticides in agriculture."

The WHO specifically calls on countries to focus on four domains to reduce preventable deaths from fungal infections and mitigate antifungal resistance: "strengthening awareness, preparedness, and response; expanding equitable access to antifungal medications and diagnostics while also boosting research into new treatments and tests; building lab networks and surveillance systems to track and detect fungal infections; and addressing social, agricultural, and environmental determinants of fungal disease and antifungal resistance."

The CDC specifically cites the number of C. auris cases reaching 13,507 from 2022-2024. There are other fungi of concern globally that cause severe infections, and even when they are not fatal, the WHO warns they can cause "chronic, debilitating illness and lasting social and economic consequences."

About the Author

Matt MacKenzie

Associate Editor

Matt is Associate Editor for Healthcare Purchasing News.

Sign up for our eNewsletters
Get the latest news and updates